Centers for Medicare & Medicaid Services extends short-term bridge program for GLP-1 obesity drug coverage

Centers for Medicare & Medicaid Services extends short-term bridge program for GLP-1 obesity drug coverage

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan. 1, 2027.

BALANCE Model for Obesity

This Viewpoint discusses a new Centers for Medicare & Medicaid Services (CMS) model to expand access to novel obesity medications and lifestyle interventions for Medicare and Medicaid beneficiaries.